HA、SCGRIA与常规肝功联检对慢性肝病的临床鉴别诊断价值

The Clinical Values of the Combined Determination of Serum HA,SCG and the Routine Liver Function to Discriminate and Diagnose Chronic Liver Diseases

摘要: 采用 RIA法对 150例肝病患者进行血清 HA(透明质酸 )和 SCG(甘胆酸 )含量的测定。结果表明: 慢性肝病患者血清中 HA和 SCG的含量显著高于对照组 ( P<0.0 1), 与肝功其它指标和肝脏的损伤程度密切相关。提示对血清进行 HA和 SCG检测及其与常规肝功联合检测是目前对慢性肝病鉴别诊断的理想指标。

Abstract: The content of serum HA and SCG is determined by RIA in 150 patients of chronic liver diseases.The results show that the content of serum HA and SCG in the patients of chronic liver diseases is evidently higher than that of the comparison team ( P <0.01), and closely related to the other targets of liver function and the degree of the liver damage. It suggests that the test of serum HA and SCG and their combined test are the ideal targets for discriminating and diagnosing chronic liver diseases.